Table 1. Estimated MRONJ case numbers in the US based on MRONJ incidence for the major underlying diseases*.
Underlying diseases | New cases in the US (Year) | MRONJ incidence | Estimated MRONJ cases (Year)* |
---|---|---|---|
Multiple myeloma | 34,920† | 5.16% (Rugani et al., 2016) | 1,802 |
Breast cancer | 330,840‡ | 2.09% (Rugani et al., 2016) | 6,915 |
Prostate cancer | 248,530† | 3.80% (Rugani et al., 2016) | 9,444 |
Osteoporosis/Low bone mass | 53,500,000§ | 0.01% (Khan et al., 2017) | 5,350 |
Estimated annual incidents of MRONJ | 23,511 |
MRONJ: Medication-related osteonecrosis in the jawbone.
Based on an assumption that all these patients were treated by antiresorptive medications.
American Cancer Society. Cancer Facts & Figures 2021. Atlanta, Ga: American Cancer Society; 2021.
Invasive breast cancer and ductal carcinoma: American Cancer Society. How Common Is Breast Cancer? Jan. 2020. Available at: https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html.
Center for Disease Control and Prevention at: https://www.cdc.gov/nchs/products/databriefs/db405htm.